385.211 Refractory and intractable epilepsy treatment and research at recognized medical centers.—
(1) As used in this section, the term “low-THC cannabis” means “low-THC cannabis” as defined in s. 381.986 that is dispensed only from a dispensing organization as defined in s. 381.986.
(2) Notwithstanding chapter 893, medical centers recognized pursuant to s. 381.925 may conduct research on cannabidiol and low-THC cannabis. This research may include, but is not limited to, the agricultural development, production, clinical research, and use of liquid medical derivatives of cannabidiol and low-THC cannabis for the treatment for refractory or intractable epilepsy. The authority for recognized medical centers to conduct this research is derived from 21 C.F.R. parts 312 and 316. Current state or privately obtained research funds may be used to support the activities described in this section.
History.—s. 3, ch. 2014-157.
Section: Previous 385.101 385.102 385.103 385.202 385.203 385.204 385.206 385.207 385.211 385.212 NextLast modified: September 23, 2016